Article Listing - Stock Commentary - Europe

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

Sales of beta-2 agonists in Europe will grow from $485 million in 1990 to almost $983 million by 1995, or...

TAMOXIFEN OF BENEFIT IN OSTEOPOROSIS?

6 April 1992

A US study looking at the effects of Imperial Chemical Industries' synthetic anti-estrogen Nolvadex (tamoxifen) in post-menopausal women with early-stage...

BIOSCIENCE/FUTURE MEDICAL DEAL

6 April 1992

Bioscience International has reached an agreement with Future Medical Products to begin testing of a product used to neutralize HIV....

DURAMED'S ISONIAZID

6 April 1992

The resurgence of tuberculosis brought about by the AIDS epidemic has caused generic drugs company Duramed Pharmaceut-icals to resume manufacture...

AUSTRALIAN VACCINE RESEARCH

6 April 1992

The Walter and Eliza Hall Institute of Medical research in Melbourne, Australia, is to set up a commercial joint venture...

GERMAN PRICE SUPPORT EXTENDED

6 April 1992

The leading German health insurance funds have announced further fixed-price support arrangements for a new range of drug products, and...

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

Favorable trends in drugs business and especially good sales of standard products such as aspirin are reported to have helped...

1991 OUTSTANDING YEAR FOR AMERICAN HOME

6 April 1992

New sales and earnings records were achieved in 1991 by American Home Products (Mar-ketletter January 20). The year was said...

ROBERTS PHARMA ACQUIRES NCRC

6 April 1992

The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...

WHO BUDGET CRISIS IMPACT ON STAFF

6 April 1992

Staff of the World Health Organiz-ation, as a result of the budget crisis, are "deeply concerned not only about their...

Showing 94431-94440 of 95365 articles